KAUST and the King Salman Center for Disability Research (KSCDR) have signed an MoU to collaborate on the diagnosis, management, and treatment of disabilities affecting Saudi citizens and residents. The partnership will focus on neurodevelopmental conditions, learning disabilities, visual impairments, speech disorders, and mobility impairments. KAUST's Center of Excellence for Smart Health, launched on July 1, will be a key component, leveraging its supercomputing resources and genome sequencing capabilities. Why it matters: This partnership aims to address the increasing prevalence of chronic diseases and disabilities in Saudi Arabia, aligning with national research priorities and improving the quality of life for people with disabilities.
Construction has begun on a 30 million-square-foot data center in Saudi Arabia to support government services. The facility will provide infrastructure for storing and processing data related to citizen services, national security, and economic development initiatives. The project aims to enhance the Kingdom's digital capabilities and data sovereignty. Why it matters: This investment signals Saudi Arabia's commitment to building a robust digital infrastructure and advancing its Vision 2030 goals.
KAUST researchers have identified the gene 'CIROZ' as responsible for pediatric heart defects and misplacement of internal organs, working with institutes in Saudi Arabia and worldwide. The research examined samples from 16 patients from 10 families, including four from Saudi Arabia, revealing CIROZ's role in embryonic development symmetry. The findings provide insights into heritable diseases, which are more prevalent in Saudi Arabia. Why it matters: Identifying this gene allows for focused research on preventative strategies and curative therapies for congenital heart defects, particularly relevant in regions with higher rates of such diseases.
This study investigates the correlation between Google Trends data for COVID-19 symptoms and the actual number of COVID-19 cases in Saudi Arabia between March and October 2020. The researchers found that searches for "cough" and "sore throat" were most frequent, while "loss of smell", "loss of taste", and "diarrhea" showed the highest correlation with confirmed cases. The study concludes that Google searches can serve as a supplementary surveillance tool for monitoring the spread of COVID-19 in Saudi Arabia. Why it matters: The research demonstrates the potential of using readily available digital data to augment traditional surveillance methods for public health monitoring in the region.
The Research Products Development Company (RPDC) signed an agreement with The Saudi Vaccine and Biomanufacturing Center (SVBC) to establish a research and industrial center in Saudi Arabia for vaccine and biopharmaceutical development. Supported by KACST and hosted by KAUST, the SVBC will provide a state-of-the-art facility and a training platform. Cooperation agreements were also signed with GE for equipment supply and with Fujifilm Dayosent Biotechnology for MERS-CoV treatment development. Why it matters: This initiative aims to localize vaccine and advanced treatment industries in Saudi Arabia, create technical jobs, and reduce reliance on imports in line with Vision 2030.
Construction has begun on a 30 million square foot data center in Saudi Arabia for use by the Saudi government. The project was announced by the Saudi Ministry of Investment. No details were provided regarding the location, cost, or timeline for the build. Why it matters: This investment signals the Kingdom's intent to develop significant digital infrastructure to support its Vision 2030 goals and emerging AI sector.
Khaled Alsayegh at the King Abdullah International Medical Research Center is creating a Saudi Stem Cell Donor Registry, with 80,000 potential donors identified. The aim is to identify universal donors, reprogram their cells into induced pluripotent stem (iPS) cells, and create a gene bank for matched tissue transplants. Alsayegh is collaborating with Jesper Tegnér at KAUST to create pacemaker cells using single-cell RNA sequencing. Why it matters: This initiative could revolutionize precision medicine in KSA by providing readily available, matched cells for transplants, reducing the need for patient-specific reprogramming and improving treatment outcomes.